Clinical Trial Update: Cyclosporine Implant for Ocular Graft-Versus-Host Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a cyclosporine implant for ocular graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Cyclosporine implant (cyclosporine)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Graft Vs Host Disease | Phase 1 | Status: COMPLETED